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IntroductIon
Unlike most other human cancers, the presence of 
thyroid metastatic disease does not relate with poor 
prognosis and the overall long term survival is re-
ported to be approximately 50%1. There is no doubt 
that the usual multiplicity of the thyroid metastatic le-
sions in both lungs in concordance with their fairly 
good therapeutic response to 131I, disables the role of 
any surgical approach. But similarly, the incidence of 
thyroid metastatic disease alone does not seem to set 
a contraindication for thoracotomy in case of a new 
presented synchronous primary lung cancer.
In such cases the assessment of origin of any neo-
plasmatic disease in the lungs or elsewhere (M dis-
ease) should be primary based on previous CT scans, 
which can differentiate the old metastatic thyroid le-
sions from any new presented ones, which can be con-
sidered as of lung origin.
Anyhow, such a similar differentiation concerning 
the infiltration of mediastinal lymph nodes (N disease) 
is harder to make, since both NSCLC and papillary 
thyroid carcinoma tend to metastasize to the ante-
rior mediastinum2. As a result, the specificity of all 
preoperative procedures, including medistinoscopy, 
integrated PET/CT and scanning with 131I, to detect 
lymph nodes with pulmonary disease is dramatically 
diminished. One could propose that nodes detected 
with PET/CT and not with 131I are exclusively derived 
from the lung cancer. But this can not be the rule, as it 
is common for longstanding thyroid metastatic lesions 
to undifferentiate and thus, not to uptake 131I. 
According to all the above we considered that 
the intraoperative complete lymph node dissection 
could be the only reliable staging procedure for the 
NSCLC.
Case RepoRt
debatable results of surgery for lung cancer in a patient  
with long existing pulmonary metastases from differentiated  
thyroid carcinoma.
Ilias A. Kouerinis1, Dimitrios N. Exarhos1, Nikolaos Papathanasiou1,  
Michalis E. Argiriou1, Anna Ntalipi2, Kostas Triantafillou2, Ion P Bellenis1
1Evangelismos Hospital, Athens, Greece 
2Hippokration Hospital, Athens, Greece
ABStrAct: Introduction: The appropriate following treatment in a patient with a new presented non-small cell lung cancer 
(NSCLC) and history of chronic lung metastases of thyroid origin has never been reported. In such cases, the presence of long-
standing thyroid metastatic disease with proven “limited malignant potential” could be considered as a minor treatment problem 
justifying one’s the decision to focus on the primary lung carcinoma as the only serious threat for the patient’s life.
Case report: We report the surgical treatment of a new presented NSCLC in a patient with chronic lung metastases of thyroid 
origin and we present all the diagnostic, staging and treatment problems.
Conclusion: The therapeutic results of our surgical approach were not encouraging. This could be owed to our staging prob-
lems of NSCLC and the well documented limited immunological response of such patients with multiple neoplasms. 
Key Words: Lung cancer diagnosis and staging, Lung cancer surgery, Metastasectomy, Synchronous carcinomas, Thyroid 
cancer.
Corresponding author: Ilias A. Kouerinis, Doukissis Plakentias 46, Melissia, Athens, Greece, Tel. 6932 713171, Fax: 
210 7224449, email: ikouerinis@hotmail.com
50 Aristotle University Medical Journal, Vol. 37, Issue 3, October 2010
Case presentation
A 55-year-old man was referred to our hospital with 
the diagnosis of squamous cell lung carcinoma and 
synchronous bilateral pulmonary metastases from 
papillary thyroid cancer (Figure 1). The patient had 
history of left thyroid lobectomy for the same thyroid 
pathology at the age of 15, but despite the existence 
of multiple pulmonary and mediastinal metastatic le-
sions he had never received any additional treatment. 
His follow-up had been based on sporadically taken 
x-rays and CT scans of the chest, which were almost 
invariable for 40 years, until recently, when a central 
located tumor of the upper left lobe was diagnosed. 
The final diagnosis was set by bronchoscopy and his 
pretreatment staging including MRI of the brain, CT 
abdominal scans, and bone scintigraphy revealed ab-
sence of any metastatic disease in solid organs. 
We considered that the chronic presence of me-
diastinal lymphatic disease from the thyroid gland 
(Figu res 1, 2) proved by his previous CT scans as 
well, would affect dramatically the specificity of both 
medistinoscopy and integrated PET/CT together with 
131I to detect lymph nodes with pulmonary metastatic 
disease; therefore we decided to complete the staging 
of our patient intraoperatively. 
At operation, all visible lymph nodes were re-
moved and sent for frozen section. As soon as we got 
the negative answer for pulmonary metastatic disease 
(absence of N2 disease preoperative NSCLC staging Ib 
or IIb), we continued the operation and we performed 
a typical pneumonectomy (Figure 3) since the tumor 
was found to extend beyond the fissure invading the 
lower lobe as well. Following pneumonectomy, the 
patient underwent also a completion thyroidectomy in 
order to facilitate the possible postoperative 131I up-
take from the remaining thyroid metastatic lesions. 
Permanent sections confirmed the histology for 
both thyroid metastases (Immunophenotype: Thy-
reoglobulin+, LeuM1-, TTF1-) and the lung carci-
noma (Immunophenotype: CK8- 18+, CK7+, TTF1+, 
CK20-, 34βE12+, Thyreoglobulin-) revealing also 
invasion of 2 out of 22 found intrapulmonary nodes 
[stations 12,13-postoperative staging IIb (T2, N1, 
M0)]. The patient recovered uneventfully and was 
discharged home in good condition.
Postoperatively, he received therapeutic doses 
Figure 1. Primary malignant lesion and small metastatic 
nodule in the left upper lobe. Note the egg-shell lymph node 
calcification in the right paratracheal space causing slight 
forward displacement of the trachea.
Figure 2. Post operative scanning with 131I. Note the mas-
sive 131I uptake from the mediastinal lymph nodes and from 
the two longstanding thyroid metastatic lesions in the right 
lower lobe (present in both thorax and upper abdominal 
scans). Compare with figure 1c.
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170 mCi 131I for the control of the thyroid metastases 
as well as thoracic radiation therapy (45 Gy over 5 
weeks) for his lung carcinoma. Although the suppres-
sion of the thyroid metastatic disease proved satisfac-
tory (Figure 2), brain and liver metastases appeared 
21 months later. The patient received adjuvant therapy 
(3 cycles of i.v. docexatel, cis-platin and gemcitabile 
HCl), but he died in the next 7 months from dissemi-
nated disease.
dIScuSSIon
Thyroid cancer represents an exceptional biological 
tumor with favorable prognosis even with the exis-
tence of distant metastases. It is well-documented that 
the incidence of thyroid metastatic disease at the time 
of initial presentation in differentiated thyroid cancer 
is approximately 4 %2.
Metastatic spread of papillary carcinoma occurs to 
the jugular and the anterior mediastinal nodes, lungs, 
liver, bones and elsewhere. Pulmonary metastases are 
usually bilateral and multiple, responding well to ra-
dioactive iodine therapy. Therefore they do no fulfil 
the general selection criteria for metastasectomy: ab-
sence of metastases to other nonpulmonary sites, ad-
equate pulmonary function to tolerate resection, lack 
of any other effective treatment. 
The “least malignant” biological behaviour of dif-
ferentiated thyroid cancer- proved from the long his-
tory of thyroid metastatic disease of our case as well- 
justified our decision to consider the NSCLC as the 
only threat for the patient’s life. But unfortunately, the 
longstanding mediastinal lymphatic disease derived 
from the papillary thyroid cancer made the assess-
ment of the N2 nodal status for his lung carcinoma 
very uncertain. 
Although there is no definite way for lymphatic 
spreading in relation to the location of the NSCLC, 
right lung tumors originating in the upper lobe main-
ly metastasized to level No. 4, while tumors of the 
middle lobe spread to stations Nos. 4 and 7, and those 
in the lower lobe to level No. 73. In our patient the 
assessment of infiltration or not of these nodes with 
pulmonary disease was not made preoperatively since 
thyroid cancer had already metastasized to the same 
stations (Figure 1). 
The specificity of PET/CT together with 131I scans, 
to differentiate the pulmonary from the thyroid nod-
al metastatic disease is null. One could propose that 
nodes detected with PET/CT and not with 131I are ex-
clusively derived from the lung cancer. But this can 
not be the rule, as it is common for longstanding thy-
roid metastatic lesions to undifferentiate and thus, not 
to uptake 131I. 
The interest for the infiltration or not of mediasti-
nal lymph nodes with pulmonary disease is more than 
theoretic, since it will finally determine the following 
treatment. Mediastinoscopy has always a central role 
in the decision-made to proceed or not with lung re-
section even in the presence of other nodal pathology. 
For this reason, reconsidering our case we believe that 
mediastinoscopy should have been performed, despite 
its predicted low sensitivity in our patient.
On the other hand, aggressive surgical resection 
is strongly recommended for such individuals with 
multiple neoplasms which have proven limited im-
munological response. Re-reviewing our treatment 
options, we conclude that the decision for surgery was 
justified, but it should be followed by early aggressive 
adjuvant treatment as well. This could prolong the 
limited survival of our patient who finally died from 
advanced disease. 
The only limitation for surgery may result from 
the pulmonary fibrosis which usually complicates the 
following radioactive iodine therapy4. Any patient 
Figure 3. Post-pneumonectomy chest X-ray showing the 
remaining thyroid metastatic disease in the right lung.
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with border respiratory parameters or other pulmo-
nary problems5 may show impairment of his respira-
tory function; in such a case an alternative treatment 
should be considered.
Several additional general conclusions may also 
arise from this unique report. First of all, in cases of 
lung cancer with multiple pulmonary nodules the tho-
racic surgeon must have histologic confirmation about 
the nature of the satellite lesions, rather than consider 
them as T4 or M1 originating from the primary site. If 
such a staging misinterpretation occurs, we may leave 
inside the patient a quite resectable tumor. Second, if 
the satellite lesions proved to originate from the thy-
roid gland as in our case, we must remember that thy-
roid metastases may respond fairly well to 131I on con-
dition that the levels of serum thyroglobulin (Tg) after 
endogenous or exogenous TSH stimulation are higher 
than 10 microg/L2.Of course, total thyroidectomy is 
essential for the 131I intake from the satellite lesions6. 
And finally, long-term follow up is crucial as stunning 
of the thyroid metastases may follow the initial diag-
nostic or treatment doses of 131I7. 
concluSIon
The therapeutic results of lung resection in the pres-
ence of multiple chronic thyroid metastases from a 
differentiated papillary carcinoma are debatable. The 
reason for this can be the false indication for surgery 
arising from the staging problems concerning mostly 
the determination of N disease as well as the limited 
immunological response of such patients with mul-
tiple neoplasms. 
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ΠΕΡΙΛΗΨΗ: Εισαγωγή: Η πλέον κατάλληλη θεραπεία για τον μη μικροκυτταρικό καρκίνο του πνεύμονα σε ασθενή με 
χρόνιες πνευμονικές μεταστάσεις θυρεοειδικής προέλευσης δεν έχει μέχρι σήμερα περιγραφεί. Σε ανάλογες περιπτώσεις, 
η παρουσία χρόνιας  μεταστατικής νόσου θυρεοειδικής  προέλευσης με αποδεδειγμένη «περιορισμένη κακοήθη δυναμική» 
θα μπορούσε να θεωρηθεί ως ελλάσον θεραπευτικό πρόβλημα, δικαιολογώντας την απόφαση του θεράποντος να εστιάσει 
στον πρωτοπαθή καρκίνο του πνεύμονα ως τη μόνη σοβαρή απειλή για τη ζωή του ασθενούς. 
Περιγραφή του περιστατικού: Παρουσιάζουμε τη χειρουργική θεραπεία πρωτοεμφανιζόμενου μη μικροκυτταρικού καρκίνου 
του πνεύμονα σε ασθενή με χρόνιες πνευμονικές μεταστάσεις θυρεοειδικής προέλευσης και συζητούμε όλα τα προβλήματα 
διαγνωστικά, σταδιοποίησης και θεραπευτικής αντιμετώπισης.
Συμπέρασμα: Τα θεραπευτικά αποτελέσματα της χειρουγικής μας προσέγγισης δεν ήταν ενθαρρυντικά. Αυτό μπορεί να 
οφειλόταν τόσο στα προβλήματα που αντιμετωπίσαμε στην σταδιοποίηση του καρκίνου του πνεύμονα όσο και στην γνωστή 
σε όλους μας καταστολή του ανοσοποιητικού συστήματος που εμφανίζουν τέτοιοι ασθενείς με πολλαπλά νεοπλάσματα. 
Λέξεις Κλειδιά: Καρκίνος του πνεύμονα διάγνωση και σταδιοποίηση, Χειρουργική αντιμετώπιση καρκίνου του πνεύμονα, 
Μεταστασεκτομή, Σύγχρονα καρκινώματα, Καρκίνος του θυρεοειδούς.
Αμφίβολα τα αποτελέσματα της χειρουργικής θεραπείας σε ασθενή  
με καρκίνο του πνεύμονα και χρόνιες πνευμονικές μεταστάσεις  
από διαφοροποιημένο καρκίνο θυρεοειδούς.
Ηλίας Α. Κουερίνης1, Δημήτριος Ν. Έξαρχος1, Νικόλαος Παπαθανασίου1,  
Μιχάλης Ε. Αργυρίου1, Άννα Νταλίπη2, Κώστας Τριανταφύλλου2, Ίων Π. Μπελλένης1
1ΠΓΝΑ «Ο Ευαγγελισμός», Αθήνα, Ελλάς 
2ΠΓΝΑ « Ιπποκράτειον», Αθήνα, Ελλάς
rEFErEncES
